

Coca-Cola Europacific Partners vs Kimberly-Clark
Major Coca-Cola bottler across Europe and Asia-Pacific vs Global maker of tissue and personal care products. Which is the better buy for your portfolio in August 2026? Plain-English answer below.
Coca-Cola Europacific Partners bottles and distributes Coke products across Western Europe and Australia under a long-term franchise agreement with the Coca-Cola Company, while Kimberly-Clark sells Kleenex, Huggies, and Scott paper products to households around the world. Coca-Cola Europacific Partners vs Kimberly-Clark both generate predictable cash flows from consumer staples brands with deep shelf-space dominance, making them favorites for dividend investors. The analysis examines organic revenue growth, volume trends, cost pass-through ability, and which company delivers stronger earnings per share growth.
Coca-Cola Europacific Partners bottles and distributes Coke products across Western Europe and Australia under a long-term franchise agreement with the Coca-Cola Company, while Kimberly-Clark sells Kl...
Why It’s Moving

CCEP slips on valuation caution as analysts flag a harder setup after the rally
- Kepler Cheuvreux downgraded CCEP from Hold to Reduce, saying the shares look stretched after a strong run and that the valuation premium may be hard to justify if sentiment cools.
- The firm still lifted its target price, but the downgrade itself signals caution: analysts see limited room for further upside and more risk of a pullback if the market re-rates the stock.
- Recent earnings have been solid, yet investors are weighing that against a tougher second half with fewer selling days, harder comparisons, and ongoing commodity and geopolitical cost pressure.

Kimberly-Clark is moving on mixed analyst optimism as growth concerns keep the upside story in check.
- Analysts are still broadly constructive on Kimberly-Clark, with consensus models showing a moderate upside case, but the signal is mixed rather than emphatic, suggesting investors are weighing stability against slower growth.
- Recent estimates point to softer North America category momentum and negative organic sales expectations, which can pressure sentiment because it implies limited near-term revenue acceleration even as the company defends margins.
- The stock remains tied to expectations around cost controls, portfolio simplification, and execution on efficiency gains, so any sign of better-than-expected savings or steadier demand can help support the shares.

CCEP slips on valuation caution as analysts flag a harder setup after the rally
- Kepler Cheuvreux downgraded CCEP from Hold to Reduce, saying the shares look stretched after a strong run and that the valuation premium may be hard to justify if sentiment cools.
- The firm still lifted its target price, but the downgrade itself signals caution: analysts see limited room for further upside and more risk of a pullback if the market re-rates the stock.
- Recent earnings have been solid, yet investors are weighing that against a tougher second half with fewer selling days, harder comparisons, and ongoing commodity and geopolitical cost pressure.

Kimberly-Clark is moving on mixed analyst optimism as growth concerns keep the upside story in check.
- Analysts are still broadly constructive on Kimberly-Clark, with consensus models showing a moderate upside case, but the signal is mixed rather than emphatic, suggesting investors are weighing stability against slower growth.
- Recent estimates point to softer North America category momentum and negative organic sales expectations, which can pressure sentiment because it implies limited near-term revenue acceleration even as the company defends margins.
- The stock remains tied to expectations around cost controls, portfolio simplification, and execution on efficiency gains, so any sign of better-than-expected savings or steadier demand can help support the shares.
Investment Analysis
Pros
- Reported solid Q3 2025 revenue growth of 1.0%, driven by volume growth and higher revenue per unit case.
- Continues to increase market share ahead of competition within its territories.
- Receives mostly positive analyst sentiment, with an average price target indicating upside potential near 9-19%.
Considerations
- Modest volume growth at only 0.4% in Q3 suggests limited near-term expansion in core beverage sales.
- Analyst opinions are mixed, with some Hold and Sell ratings alongside Buy recommendations, reflecting some uncertainty.
- Short selling activity remains notable at 8.88%, indicating some investor bearishness or hedging.
Pros
- Kimberly-Clark's price-to-earnings ratio of 16.27 is below its 3-, 5-, and 10-year averages, potentially indicating value relative to its history.
- Market capitalization around $31 billion reflects its status as a leading global consumer goods company.
- Maintains steady financial metrics amid competitive pressure in personal care and household products.
Considerations
- Current PE ratio below historical averages may partly reflect slower growth or margin pressure concerns.
- Faces industry-wide challenges including inflationary cost pressures and evolving consumer preferences.
- Competitive dynamics could impact pricing power and margin sustainability in key product categories.
Coca-Cola Europacific Partners (CCEP) Next Earnings Date
The next earnings date for CCEP is not yet officially announced, but it is currently estimated for August 5–10, 2026. Based on the company’s historical reporting pattern, that release would most likely cover the second quarter of 2026. One published calendar lists August 12, 2026 as a forecasted date, so the expected window is still subject to revision.
Kimberly-Clark (KMB) Next Earnings Date
KMB’s next earnings date is expected on August 4, 2026. The release should cover Q2 2026 results. That timing aligns with the company’s typical late-summer earnings cycle.
Coca-Cola Europacific Partners (CCEP) Next Earnings Date
The next earnings date for CCEP is not yet officially announced, but it is currently estimated for August 5–10, 2026. Based on the company’s historical reporting pattern, that release would most likely cover the second quarter of 2026. One published calendar lists August 12, 2026 as a forecasted date, so the expected window is still subject to revision.
Kimberly-Clark (KMB) Next Earnings Date
KMB’s next earnings date is expected on August 4, 2026. The release should cover Q2 2026 results. That timing aligns with the company’s typical late-summer earnings cycle.
Buy CCEP or KMB in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.


